Talking to ET Now, Abhay Laijawala , Head-India Research, says Deutsche Equities is overweight on IT but continues to be underweight on pharma as further price erosion is seen in next few months. Is it time to buy the fear into IT? Let us be clear here. Read more here: Go contrarian on IT, 75% of growth drivers normalising: Abhay Laijawala, Deutsche Equities
Read More Here: Go contrarian on IT, 75% of growth drivers normalising: Abhay Laijawala, Deutsche Equities
No comments:
Post a Comment